AGBI.F Stock Overview
Atlas Global Brands Inc. operates as a cannabis company in Australia, Canada, Denmark, Germany, Israel, Norway, Spain, and the United Kingdom.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Atlas Global Brands Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.02 |
| 52 Week High | CA$0.25 |
| 52 Week Low | CA$0.01 |
| Beta | 0 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 100.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| AGBI.F | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | -0.09% | 0.4% |
| 1Y | n/a | 19.0% | 32.6% |
Return vs Industry: Insufficient data to determine how AGBI.F performed against the US Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how AGBI.F performed against the US Market.
Price Volatility
| AGBI.F volatility | |
|---|---|
| AGBI.F Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 9.5% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 15.0% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: AGBI.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine AGBI.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Bernie Yeung | atlasglobalbrands.com |
Atlas Global Brands Inc. operates as a cannabis company in Australia, Canada, Denmark, Germany, Israel, Norway, Spain, and the United Kingdom. It is involved in cannabis cultivation, manufacturing, scalability, marketing, distribution, and pharmacy activities. The company is based in Chatham, Canada.
Atlas Global Brands Inc. Fundamentals Summary
| AGBI.F fundamental statistics | |
|---|---|
| Market cap | US$17.57m |
| Earnings (TTM) | US$26.05m |
| Revenue (TTM) | n/a |
0.0x
P/E Ratio0.0x
P/S RatioIs AGBI.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AGBI.F income statement (TTM) | |
|---|---|
| Revenue | CA$0 |
| Cost of Revenue | CA$0 |
| Gross Profit | CA$0 |
| Other Expenses | -CA$26.05m |
| Earnings | CA$26.05m |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.16 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 77.0% |
How did AGBI.F perform over the long term?
See historical performance and comparison